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 1 
CHAPTER 1 
 
Introduction 
 
1.1. Clinical need for reduction of A. baumannii transmission 
 
Acinetobacter baumannii, a Gram-negative coccobacillus with a multi-drug resistant 
(MDR) phenotype, is commonly found in soil, water, mucous membranes, vegetables, and on 
human skin [1]. Individuals with a compromised immune system, diabetes, or wounds can suffer 
from life-threatening infections resultant from A. baumannii. These infections can lead to 
widespread inflammation, blood clotting, multiple organ failure, pneumonia, septic shock, and 
death [1]. A. baumannii is responsible for 2% to 10% of Gram-negative bacterial infections 
worldwide and has an associated mortality rate reaching up to 70% [2]–[4].  
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1.2. A. baumannii presence in water supplies 
 
The spread of A. baumannii occurs via human contact and through contact with 
contaminated food, soil, water, or hospital equipment [5].  A. baumannii has been detected in 
freshwater ecosystems, sewage, wastewater, drinking water, and groundwater supplies [5], [6]. 
Infections resultant from A. baumannii and other Gram-negative bacteria can be transmitted by 
contaminated drinking water [7]. Freshwater and marine water ecosystems are natural sources of 
Acinetobacter species and can also serve as effective means of Acinetobacter transmission.  
Mortality rates attributed to A. baumannii nosocomial infections are 20-70%, which is higher 
than most other bacterial species. Therefore, steps must be taken to prevent the transmission of 
infections caused by A. baumannii. Elimination of A. baumannii from water is one important 
step that can be taken to reduce the transmission of this bacterium.  
1.3. Methods used to reduce microorganism contamination of water supplies 
 
It is well documented that many public health and environmental problems are resultant 
from contamination of water with microorganisms, including A. baumannii [8],[9].  In 2014, it 
was reported by the World Health Organization that over 1.8 billion people use a contaminated 
water supply, with the poor being most heavily affected. The consequences of this situation are 
dire, with diarrhoeal diseases causing 842,000 deaths per year, especially in developing 
countries[10]. Many disease caused by water sanitation are resultant from pathogens that can 
survive in water or have water-related vectors.  
The emergence of new contaminants and newly developed chemical compounds has 
exposed the downfalls of current water treatment and distribution systems [11], [12]. The ever-
increasing rate of worldwide population growth continues to drive up the demand for clean water 
[13]. Also, climate changes and extended droughts have caused a shift in fresh water distribution, 
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which has led to inadequate fresh water supply to various regions around the globe [13]. Regions 
lacking fresh water supplies have made use of other water sources, such as seawater and storm 
water, to meet their water needs [14].  The use of unconventional water sources for water supply 
makes it even more important to develop effective treatment methods that clear water of 
pathogen contamination.  
The water treatment technologies currently used are limited and cannot adequately 
eliminate pathogens from all water sources. Conventional methods for removal of 
microorganisms from water include oxidation, reduction, ion exchange, precipitation, filtration, 
electrochemical treatment, chemical treatment, and solvent extraction[15]. However, the use of 
these conventional techniques are cost prohibitive and do not work efficiently for elimination of 
low concentrations of microorganisms[16]. Especially in developing countries, funding, 
governance, and access to appropriate technologies are obstacles to gaining accessible water 
sanitation systems. This difficulty in overcoming obstacles related to clean water access has 
raised interest in point-of-use (POU) water treatment methods. Large-scale water treatment 
systems present many problems to developing countries, such as high cost, need of skilled 
laborers, and construction complexity. The relatively inexpensive POU water treatment methods 
avoid these obstacles associated with large-scale water treatment projects. 
The development of an efficient POU water treatment technology has become imperative 
and has led to the interest in nano-enabled technologies for POU approaches. Nanotechnology is 
recognized as an important area of science and technology that could play a large role in 
combating the pitfalls of conventional and current POU water treatment devices[17]. It has been 
suggested that the development of nanotechnology-based POU devices could help developing 
countries meet their needs for clean water by efficiently providing safe water at a low cost[18]. 
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In recent years, technology has advanced and introduced different types of nanotechnologies to 
the water industry that may have promising outcomes. The most recent technologies studied to 
combat microorganism contamination of water sources include nanofiltration membranes, 
nanoporous ceramics, nanofibers, nanocatalysts, and magnetic nanoparticles [19]. It should be 
noted, however, that these technologies have yet to prove successful in eliminating A. 
baumannii.  
1.3.1. Nanofiltration membranes 
 
Conventional water purification processes, consisting of sedimentation, flocculation, 
coagulation, and disinfection are not able to remove some organic pollutants, such as small 
microorganisms[20]. Therefore, filtration membranes play an important role in water purification 
processes. Currently, various water purification membranes that are used include microfiltration, 
ultrafiltration, and nanofiltration for water treatment.  Membrane processes mentioned above are 
being incorporated for removal of microorganisms, particulates, and natural organic material 
from water. These membrane processes are a key component to water purification to ensure that 
infectious matter, such as bacteria, are not persisting in potable water. Due to the significance of 
filtration membranes and their role in water purification, research for new materials and water 
purification technologies is of utmost importance. Currently, researchers are developing 
nanomaterial-based membranes (i.e. carbon nanotubes, nanoparticles, and dendrimers) in order 
to contribute to the development of more efficient and cost-effective water filtration processes. 
To overcome limitations associated with conventional water treatment systems, a new 
adsorption technique based on the application of carbon nanotubes (CNTs) has been introduced 
[21]. CNT-based nanofiltration membranes allow for refinement and optimization of all 
membrane aspects, such as small and uniformed pore sizes as well as precise control of 
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membrane reactivity. CNT-based nanofiltration membranes have been shown to have a 
significantly higher adsorption capacity than conventional purification materials, such as 
activated carbon [22]. Also, CNTs exhibit shorter equilibrium times [23] and higher adsorption 
energy [24]. CNT-based membranes are able to effectively adsorb and remove biological 
contaminates, such as bacteria, from water due to their structural and functional properties. The 
aggregated mesopores of CNTs provide a large area that can adsorb contaminates the size of 
bacteria and other pathogens. Also, microbial adsorption on CNTs can occur on four different 
regions in the CNTs, providing ample space for adsorption. By specifically modifying CNTs for 
selective adsorption of pathogens, the adsorption kinetics of bacteria on CNTs is almost 
instantaneous [25]. This type of rapid, selective pathogen adsorption feature is not available 
when using activated carbon. Also, the selective adsorption feature of CNTs suggests they could 
be used for other applications, such as microorganism detection. 
Figure 1.2. Scanning electron microscopy (SEM) image of CNTs. A) SEM image of a single 
CNT with a multilayered structure. Inset: Electron diffraction spots seen in a typical electron 
diffraction pattern. B) SEM image of CNTs that were grown on quartz substrate [26]. 
 
Although CNTs present many great advantages in the realm of water treatment, various 
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concerns exist regarding the safety of CNTs. It has been reported that CNTs are toxic and can 
have a negative impact on the environment [27]. The use of CNT filters for water treatment 
poses the risk that a portion of media could be lost after repeated usage. Release of toxic CNTs 
into the environment would not only disrupt the natural ecosystem, but also have very harmful 
effects on humans if introduced into the body [28], [29]. Entry of CNTs into the human body can 
cause inflammation, fibrosis, granulomas, and cancer [28]. Clearly, there is still more work to be 
done before CNTs can be safely used for water treatment purposes. Various groups are currently 
researching the possibility of developing organic nanotubes for water purification, which are 
made from various polymers and biomaterials [30], [31]. These technologies could potentially 
avoid some downsides associated with CNTs.   
1.3.2. Nanoporous ceramics 
 
Nanoporous ceramic biomedia filtration techniques have been developed in order to treat 
contaminated water and convert pollutants into nontoxic substances[32]. For example, 
MetaMateria Technologies offers nano-enhanced ceramic products with high surface areas and 
porous structures that can host active materials, such as beneficial aerobic bioremediation 
colonies. Bioremediation is the application of the natural metabolic ability of microorganisms to 
transform organic contaminants into less harmful, non-hazardous substances[33]. These nontoxic 
substances can then be assimilated into natural biogeochemical cycles. The aerobic 
bioremediation colonies hosted within the porous ceramic material are purported to convert 
organic pollutants into nontoxic substances. Other research groups have also developed 
nanoporous ceramic membrane filters designed from ceramic nanopowders on support 
membranes[34], [35]. These nanoporous ceramic membrane filters can effectively remove 
various microorganisms from water.  
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Although nanoporous ceramic filtration systems are more fouling-resistant and 
chemically stable than polymeric-based water treatment systems, these nanoporous ceramic-
based water filtration devices do require maintenance[36]. Some devices require much time to 
allow the biolayer to establish within the ceramic material prior to use. Also, these devices must 
be frequently cleaned on the filter’s surface.   
1.3.3 Nanofibers 
Various biotechnologies have also been developed in attempt to overcome the limitations 
of current water treatment methods. Polysaccharide nanofiber biomaterials have recently been 
deemed as a very promising option for water purification purposes. Specifically, ultrafine 
chitosan nanofibers and cellulose nanofibers have been shown to have a high pathogen 
adsorption capacity in combination with high permeation flux and high rejection rates, compared 
to commercially available ultrafiltration membranes [37], [38]. These nanofibers are prepared 
naturally and are not broken down by fabrication processes, allowing them to retain high tensile 
strength following processing. Also, chitosan nanofibers and cellulose nanofibers are attractive 
options for water treatment application due to their low toxicity and high potential for surface 
modifications [38].  
Although polysaccharide nanofibers exhibit promising results in terms of water 
purification, large-scale production of these nanofibers would be very difficult. Corrosive 
acid/alkali chemicals are used to prepare cellulose and chitin nanofibers, potentially causing a 
negative environmental impact. Also, functionalizing the surface of nanofibers will prove to be 
challenging on a large scale due to the problems associated with obtaining uniformity of surface 
modification and obtaining ultrathin coatings without affecting the filter pore size [39]. 
Furthermore, low wettability, sparse nanoscale selectivity, and mechanical weakness hinder 
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nanofiber production on a large scale for water purification applications [40]. These drawbacks 
will need to be circumvented prior to nanofiber commercialization.  
 
Figure 1.3. Cellulose nanofibers imaged using SEM. A) Cellulose acetate nanofibers. B) 
Regenerated cellulose nanofibers [41].  
 
1.3.4. Nanocatalysts 
 
 Nanoscale semiconductor photocatalytic materials have been deemed as an attractive 
option for use as water treatment technology[42], [43]. These photocatalytic materials generate 
reactive oxygen species (ROS) (i.e. H2O2, OH!, O2!-, O3) upon activation, thereby causing the 
degradation of organics and inactivation of pathogens [44]. Nanoscale titanium dioxide (TiO2) 
photocatalysts have gained the most attention as a photocatalyst for water treatment purposes. 
This photocatalyst is well known for its rapid breakdown of toxins, without generating any 
secondary pollutants [44].  TiO2 remains very active and stable following repeated use as a water 
treatment technology. Many other photocatalysts, such as cadmium sulfide and gallium 
phosphide, undergo chemical breakdown and emit toxic chemicals following repeated use, 
unlike TiO2.   
Researchers have developed methods for functionalizing TiO2 in order to shift its 
excitation wavelength to the visible light region, making the material more applicable in the 
natural environment setting and extending its usefulness in areas lacking electricity. By doping 
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TiO2 with certain cationic or anionic materials, the photocatalyst can be activated by sunlight.  
These types of doped or modified nanoscale TiO2 photocatalysts have been shown to eliminate 
bacteria and other various microbes when activated [45]–[48]. The ROS emitted by activated 
nanoscale TiO2 photocatalysts break cell membranes and oxidize residual cellular debris [49], 
thereby making TiO2 photocatalyst technology a viable option for water purification.  
Although nanoscale TiO2 photocatalysts present many attributes that would be beneficial 
for water treatment purposes, the applicability of this technology for water treatment still has 
various hurdles to overcome before possible use. Nanoscale TiO2 photocatalysts are limited by 
slow kinetics and they must be continually activated by light exposure for removal of 
contaminates.  Also, the TiO2 photocatalysts tend to agglomerate during operation, thereby 
reducing surface area and reusability [44]. Furthermore, the potential release of the compounds 
coating the surface of TiO2 photocatalysts could pose a major environmental risk and negatively 
affect the ecosystem. These limitations hinder the commercialization of nanoscale TiO2 
photocatalysts for water treatment. Another problem to point out is the difficultly in setting up 
and maintaining nanoscale TiO2 photocatalyst devices, thereby hindering their usefulness as 
POU devices.  
1.3.5. Magnetic nanoparticles 
 
The nanomaterials previously discussed have drawbacks limiting usability. Limitations of 
nanofiltration membranes include slow, diffusion-limited operation and surface sites, which 
decrease the adsorption capacity of the membrane. Nanofiltration membranes can also suffer the 
consequences of rapid saturation, thereby rendering the membrane nonfunctional. Thus, the 
development of nanotechnologies with higher adsorptive capacity, low diffusion resistance, and 
fast separation is of great importance in practical engineering applications. 
 10 
Recently, magnetic nanoparticles (MNPs) have been suggested as a possible cost-
effective and efficient alternative to current water treatment materials. MNPs have a high surface 
area to volume ratio, which enables high adsorption efficiency and provides a large number of 
available surface sites. Also, the ability to easily synthesize, functionalize, and control design 
parameters of MNPs makes them very versatile. Furthermore, the low-toxicity, chemical 
inertness and biocompatibility of MNPs make them outstanding candidates for water treatment 
applications. Following water treatment, the adsorbed pollutants on the surface of the MNPs can 
be removed, allowing for effective reuse of the MNPs[50]. This characteristic makes MNPs 
more cost effective and a viable possibility for use in designing POU water treatment devices.   
Singh et al. have reported that surface-engineered MNPs allow for successful capture and 
extraction of Escherichia coli from PBS [51]. Also, Kang et al. have reported that genetically 
engineered human opsonin functionalized MNPs can be used to successfully bind and extract 
Staphylococcus aureus or Escherichia coli from biological fluid [52].  Unfortunately, very few 
nanoparticles have been shown to bind A. baumannii.  Also, many of the nanoparticles 
developed for bacterial capture are functionalized with genetically engineered, synthetic, or 
biomacromolecular ligands. Such surface functionalization may pose special challenges in 
achieving the Food and Drug Administration (FDA) approval required for many important 
applications.  Furthermore, very few reports indicate bacterial capture in less than 1 hour. This is 
a notable unmet need because rapid extraction of bacteria is essential in order to allow effective 
decision-making in assessing potential pathogen contamination and to minimize risk of infection.  
In order to address the problems of biocompatibility and rapid capture, a new and 
effective aqueous stabilized surface ligand with low regeneration cost must be engineered. 
Functionalizing MNPs with biocompatible, bacterial targeting motifs is a technique that can be 
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employed to significantly improve the efficiency of targeting pathogens in contaminated water. 
By surface functionalizing MNPs with biorecognition ligands, a large amount of free functional 
groups are available on the surface and are stable in aqueous solution, which is necessary for the 
successful adsorption of pathogens[53], [54].  Optimization of the surface ligand for rapid 
binding would enable the use of superparamagnetic MNPs for rapid removal and high separation 
efficiency of bacteria from water via the application of a magnetic field. The development of 
low-cost, bacteria-targeting ligands for MNPs must be further investigated in order to harness the 
potential of MNPs for application in the field of water treatment. Research in this area is just 
beginning and studies are needed in order to develop NPs that can be used to purify water on a 
large scale.     
1.4. Aims addressed in this thesis project 
Research presented in this thesis is aimed to develop a ligand that can be readily 
conjugated to nanoparticles for the rapid targeting and binding of A. baumannii.  The A. 
baumannii-targeting ligand is specifically designed to meet FDA requirements for 
commercialization purposes. Precise criteria are met to ensure rapid capture of A. baumannii in 
fluid using the ligand-functionalize nanoparticle system. Completion of this work will result in 
the development of a ligand that can be functionalized to the surface of nanoparticles for the 
rapid capture and removal of A. baumannii from contaminated water, thereby serving as an 
effective technology for water treatment.  
1.4.1. Synthesize and physically characterize colistin-functionalized gold nanoparticles (Col-
PEG-AuNPs)   
Colistin, a naturally occurring cationic decapeptide isolated from Bacillus polymyxa var. 
colistinus [55], is a potent broad-spectrum antimicrobial that was first used in the 1960s. The 
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cationic colistin molecule and the negatively charged lipid A component of bacterial 
lipopolysaccharide (LPS) interact both electrostatically and hydrophobically [56], [57], 
presumably allowing for Col-PEG-AuNP capture of A. baumannii. Objective 1 of this aim is to 
conjugate colistin to the AuNP surface using a heterobifunctional PEG (polyethylene glycol) 
linker.  Additional thiolated PEG, lacking colistin, will be used to passivate AuNP sites left 
unoccupied by colistin groups, thereby minimizing nonspecific interactions. Objective 2 of this 
aim is to confirm colistin conjugation to the AuNPs and to analyze biocompatibility.  
Utilizing colistin as a targeting ligand presents many advantages over synthetic, 
genetically engineered, or biomacromolecular ligands that have been used in this context [51], 
[58], [59]. One advantage is that colistin is a readily available, approved antibiotic that has been 
used in the clinical setting for decades. This design simplifies development and facilitates 
regulatory considerations relative to the use of genetically engineered or new biomacromolecular 
ligands.   
1.4.2. Evaluate and characterize Col-PEG-AuNP binding with A. baumannii  
 
Following the development of a novel colistin-functionalized nanoparticle, the effects of 
colistin surface presentation on Col-PEG-AuNPs will be examined. The in vitro binding kinetics 
of Col-PEG-AuNPs with A. baumannii will be assessed. Objective 1 of this aim is to confirm 
Col-PEG-AuNP association with A. baumannii. Objective 2 of this aim is to determine the rate of 
nanoparticle association to A. baumannii. 
1.5. Organization of Thesis 
 
Several studies will be performed to evaluate the efficacy of the conjugation method used 
to functionalize AuNPs with colistin. Also, various studies will be employed to analyze NP 
binding to A. baumannii. Chapter 2 will describe the methods of analysis used to evaluate NP 
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synthesis and A. baumannii binding kinetics. Chapter 3 contains the results and discussion 
obtained from the various studies presented in Chapter 2. 
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CHAPTER 2 
 
Materials and Methods 
 
2.1. Materials 
All materials were obtained from Sigma-Aldrich (St Louis, MO, USA) and used as 
received unless otherwise noted. 
2.2. Methods 
2.2.1. Synthesis of Col-PEG-AuNPs 
Col-PEG-AuNPs were prepared using a multistep approach 
 (i). Conjugating Colistin to NHS-PEG3400-OPSS tethers. Colistin was suspended in 100 
mM sodium bicarbonate (NaHCO3) (pH 8.5) at a concentration of 0.29 mg/mL.  NHS-PEG3400-
OPSS (succinimidyl ester-polyethylene glycol-ortho-pyridyl disulfide, Laysan Bio, Inc., Arab, 
AL, USA) was prepared in 100 mM NaHCO3 at a concentration of 3.19 mg/mL. 900 µL of NHS-
PEG3400-OPSS solution was added in drop-wise fashion to 9 mL of colistin solution. The 
solution was vortexed for 10 seconds and then allowed to react at 4°C for 2 h.  
(ii). Attachment of Colistin-PEG3400-OPSS onto AuNPs. 1.425 mL of Colistin-PEG3400-
OPSS from step (i) and an additional 75 µL of 100 mM NaHCO3 solution were added to 15 mL 
of 20 nm AuNP suspension (Ted Pella Inc., Redding, CA, USA). The solution was incubated at 
25°C for 1 h. 
(iii). Passivation of Col-PEG-AuNPs with HS-mPEG2000. 109 µM HS-mPEG2000 (thiol-
polyethylene glycol, Laysan Bio, Inc.) was prepared in distilled water. 1.5 mL of 109 µM HS-
mPEG2000 solution was added to the Col-PEG-AuNPs resultant from step (ii), and then incubated 
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at 25°C for 1 h. Following incubation, the functionalized nanoparticles were centrifuged at 
8,000g for 30 minutes. The supernatant was decanted and particles were resuspended in 70% 
ethanol. The solution was stored at 4°C for 24 h.  
2.2.2. Synthesis of polyethylene glycol-functionalized gold nanoparticles (PEG-AuNPs) 
PEG-AuNPs were prepared in three steps 
(i). Dilution of NHS-PEG3400-OPSS. NHS-PEG3400-OPSS was prepared in 100 mM 
NaHCO3 (pH 8.5) at a concentration of 3.19 mg/mL. 900 µL of NHS-PEG3400-OPSS solution 
was added in drop-wise fashion to 9 mL of 100 mM NaHCO3 solution. The solution was 
vortexed for 10 seconds and then stored at 4°C for 2 h. 
(ii). Attachment of NHS-PEG3400-OPSS onto AuNPs. 1.425 mL of NHS-PEG3400-OPSS 
solution from step (i) and an additional 75 µL of 100 mM NaHCO3 solution were added to 15 mL 
of 20 nm AuNP suspension. The solution was incubated at 25°C for 1 h. 
(iii). Passivation of PEG-AuNPs with HS-mPEG2000. 109 µM HS-mPEG2000 was prepared 
in distilled water. 1.5 mL of 109 µM HS-mPEG2000 solution was added to the PEG-AuNPs 
resultant from step (ii), and then incubated at 25°C for 1 h. Following incubation, the 
functionalized nanoparticles were centrifuged at 8,000g for 30 minutes. The supernatant was 
decanted and particles were resuspended in 70% ethanol. The solution was stored at 4°C for 24 
h.  
2.2.3. Physical characterization of Col-PEG-AuNPs and PEG-AuNPs 
Unconjugated AuNPs, Col-PEG-AuNPs, and PEG-AuNPs were centrifuged at 8,000g for 
30 minutes. The supernatant was decanted and particles were resuspended in nanopure water at a 
NP concentration of 0.5 mM. Droplets of diluted, aqueous NP suspensions were deposited on 
carbon film-backed copper grids (Ted Pella Inc.) and blotted dry. Samples were left to dry for 2 
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h at 25°C prior to imaging on a STEM operating at 200 kV (FEI Tecnai Osiris, Hillsboro, OR, 
USA) in transmission electron microscope (TEM) mode. X-rays emitted from the specimens 
were collected via a solid-state detector and recorded to form EDS spectrums using ESPIRIT 
imaging software (Bruker, Billerica, MA, USA). The specific energies of the EDS emission 
peaks were used to identify elements within each sample. 
2.2.4. Confirmation of Colistin-PEG3400-OPSS and NHS-PEG3400-OPSS conjugation to AuNPs 
Zeta potential measurements and size measurements were obtained with a Malvern 
Instruments Zetasizer (Malvern Nanosizer ZS, Malvern Instruments, U.K.) to determine surface 
charge and size of the Col-PEG-AuNPs, PEG-AuNPs, and unconjugated AuNPs. Each NP 
formulation was resuspended in dH2O (pH 7.5) at an AuNP concentration of 1.0 mM, 
respectively.  
H1 NMR spectroscopy was used to confirm colistin conjugation to the Col-PEG-AuNPs. 
All H1 NMR spectrums were recorded in deuterium oxide (D2O), pH 7.4 using a Bruker 600 
MHz spectrometer (Bruker, 600 MHz, Billerica, MA, USA). Col-PEG-AuNPs at a NP 
concentration of 5 mM were lyophilized for 24 h. The sample was resuspended in D2O and then 
centrifuged at 8,000g for 30 min. The supernatant was decanted and analyzed using H1 NMR 
spectroscopy, prior to the iodination process described below.  
The sample pellet was resuspended in D2O and five iodine crystals were added. The 
iodinated Col-PEG-AuNP sample was vortexed for 10 s, every 20 min, for the total duration of 1 
h. Iodine is a nucleophile and, therefore, attacks sulfhydryl groups present in the OPSS-
containing ligand [60]. During this reaction, nucleophilic substitution of iodine with a thiol takes 
place, thereby causing quantitative decoupling of the OPSS-containing ligands from the surface 
of the AuNPs. Iodination of AuNPs reduces their aqueous solubility and forces them to 
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spontaneously precipitate [61], leaving only OPSS-containing ligand and iodine in the 
supernatant. 
Following 1 h of periodic vortexing, the sample was stored at 4°C for 24 h to allow the 
iodine crystals to settle at the bottom of the suspension. Then, only Colistin-PEG3400-OPSS 
ligand remained in suspension and was extracted for analysis using H1 NMR spectroscopy. The 
same procedure was used to analyze the NHS-PEG3400-OPSS ligand of the PEG-AuNPs. Also, 
free colistin (6.5 mM) in D2O was analyzed using H1 NMR spectroscopy.   
2.2.5. Cell culture 
HepG2 cells (human liver carcinoma cancer cell line) were cultured in Dulbecco's 
modified Eagle's medium (DMEM, Gibco Cell Culture, Carlsbad, CA, USA) supplemented with 
10% fetal bovine serum (FBS, Gibco) at 37°C in a humidified atmosphere containing 5% CO2. 
HUVEC cells (human umbilical vein endothelial cell line) were cultured in vascular basal cell 
medium (ATCC PCS-100-300, Manassas, VA, USA) supplemented with endothelial cell growth 
kit-VEGF (ATCC PCS-100-41) at 37°C in a humidified atmosphere containing 5% CO2. 
2.2.6. In vitro cytotoxicity studies 
The cytotoxicity induced by Col-PEG-AuNPs, PEG-AuNPs, and free colistin on 
mammalian cell cultures was determined using the alamarBlue (Invitrogen Co., Carlsbad, CA, 
USA) assay [62]. HepG2 and HUVEC cells were seeded in clear, flat 96-well plates at a density 
of 10,000 cells/well in 200 µL of medium and incubated for 24 h at 37°C. Next, culture medium 
was removed and exchanged with medium containing fresh Col-PEG-AuNPs and PEG-AuNPs at 
concentrations of 2, 1, 0.5, 0.25, and 0 mM, respectively.  Cells were also treated with free 
colistin at concentrations of 900, 90, 70, 15, 1 and 0 µM. After incubation for 24 h at 37°C, cells 
were washed three times with phosphate buffer solution (PBS), pH 7.4 and treated with 200 µL 
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of alamarBlue containing media. Cells were then incubated for an additional 4 h at 37°C. 
Fluorescence was quantified using a plate-reader (Tecan, Infinite M1000 Pro, Switzerland), with 
an excitation wavelength of 540 nm and emission wavelength of 590 nm.  
2.2.7. In vitro hemocompatibility 
Human whole blood was collected from anonymous, consenting human donors in 
accordance with an approved Institutional Review Board (IRB) protocol (IRB 111251). Red 
blood cells (RBCs) were isolated according to well-established protocols [63]. Four different 
concentrations (2, 1, 0.5, 0.25, and 0 mM) of Col-PEG-AuNPs and PEG-AuNPs were prepared 
in PBS, pH 7.4, respectively. Free colistin (900, 0.9, 0.4, 0.2, and 0 µM) was also prepared in 
PBS, pH 7.4. Col-PEG-AuNPs, PEG-AuNPs, and free colistin were incubated with RBCs for 1h 
at 37°C, each respectively, at the concentrations outlined above. Following incubation, the 
samples were centrifuged and the supernatant was spectrophotometrically analyzed for 
hemoglobin release using a plate-reader (Tecan, Infinite M1000 Pro) at 451 nm in order to 
determine percent hemolysis relative to the positive control (Triton X-100 detergent). The 
negative control used was PBS, pH 7.4. Percent of hemoglobin release was calculated according 
to the following equation:  
Hemoglobin  release  % = (𝑆𝑎𝑚𝑝𝑙𝑒!"#  !"     − Negative  control!"#  !")(Positive  control!"#  !"   −   Negative  control!"#  !") ∗ 100% 
2.2.8. A. baumannii binding 
A. baumannii (17978) was grown in Luria Bertani (LB) broth at 37ºC, 200 rpm until 
reaching late log phase. A. baumannii cultures (5x108 CFU/ml, pH 7.4) were exposed to Col-
PEG-AuNPs (1 mM NPs) for 1 hour at 37ºC, 200 rpm prior to centrifugation at 8,000g for 20 
min to pellet the cells. The supernatant was discarded, and the cells were washed two times with 
sterile dH2O prior to STEM imaging. To fix the cells, 2% formaldehyde was added, and the 
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samples were incubated for 30 min at 25°C. Droplets of Col-PEG-AuNP bacteria suspension 
were deposited on carbon film-backed copper grids (Ted Pella Inc.) and blotted dry. Samples 
were left to dry for 2 h at 25°C prior to imaging on a STEM operating at 200 kV (FEI Tecnai 
Osiris) in STEM mode. The same procedure was repeated using PEG-AuNPs. X-rays emitted 
from the specimens were collected and recorded to form EDS spectrums using ESPIRIT imaging 
software, allowing for elemental analysis.  
2.2.9. AuNP standard concentration curve 
The concentration of AuNPs was quantified using absorbance techniques, from which a 
standard concentration curve was generated. AuNPs were resuspended in PBS, pH 7.4 and 
diluted to various concentrations (2.0, 1.5, 1.0, 0.75, 0.5, 0.25, 0.12, 0 mM). 200 µL of each 
sample was plated in a 96-well plate. Absorbance was quantified using a plate-reader (Tecan, 
Infinite F500, Switzerland), with an absorbance wavelength of 492 nm. A standard concentration 
curve was generated from the data and is shown in the Appendix as Figure S5.  
2.2.10. A. baumannii binding kinetics 
The rate of nanoparticle association to A. baumannii was analyzed using a spin 
filtration/absorbance technique. Initially, A. baumannii was grown in LB at 37ºC, 200 rpm until 
reaching late log phase. A. baumannii diluted in PBS, pH 7.4 (5x108 CFU/ml) was then exposed 
to Col-PEG-AuNPs (1 mM) and PEG-AuNPs (1 mM), respectively, for various times (0, 5, 10, 
20, 30, 60, 120 min) prior to centrifugation at 4,900g for 1 min to pellet all of the bacteria, 
including the nanoparticle-bound bacteria. 200 µL of the supernatant, which now contained only 
nanoparticles, was plated in a 96-well plate. Absorbance was quantified using a plate-reader 
(Tecan Infinite F500), with an absorbance wavelength of 492 nm. Results were then compared to 
the AuNP standard concentration curve (2.2.9.) in order to determine the concentration of 
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nanoparticles unbound to bacteria. From this, the number of nanoparticles bound to bacteria was 
estimated. 
2.2.11. Statistical analysis 
All experiments were performed in triplicate. The results were expressed as the 
arithmetic mean ± standard deviation (SD). Samples were compared by one-way analysis of 
variance (ANOVA). A post hoc comparison test was utilized to discriminate between groups of 
means. The factor was declared significant if the probability of the null hypothesis was < 5% (p-
value < 0.05). 
2.2.12. Ethical compliance  
Human whole blood was collected from anonymous donors in accordance with an 
approved IRB protocol (IRB 111251). 
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CHAPTER 3 
 
Results 
 
3.1. Preparation of Col-PEG-AuNPs and PEG-AuNPs 
Colistin was tethered to AuNP surfaces using heterobifunctional PEG, as depicted in 
Scheme 1. NHS was used to couple the PEG group to any single, equivalently reactive amine 
residue of colistin. Upon entering an aqueous environment, the NHS groups of the NHS-
PEG3400-OPSS linker covalently bind to the amine groups of the colistin antibiotic via 
carbodiimide chemistry, resulting in amide bonds [64], [65]. The sulfur groups of the OPSS end 
of the heterobifunctional PEG have a strong affinity for the gold surfaces of the AuNPs. 
Therefore, use of the PEG heterobifunctional linker enabled colistin decoration of the AuNP with 
a PEG molecular spacer, which was designed to reduce steric hindrance of colistin binding to 
bacteria. Thiolated PEG (HS-PEG2000) was used to passivate the AuNP surface unoccupied by 
the Colistin-PEG3400-OPSS. This additional PEG was intended to further passivate the Col-PEG-
AuNPs, reduce nonspecific binding onto the gold surface, and sterically stabilize the NPs in both 
biological and non-biological fluids. In the range of physiological pH values, between pH 7.0 
and 8.5, the primary amine groups of colistin were protonated, and, therefore, positively charged 
[66], [67]. The positive charge of colistin allowed for binding to the negatively charged outer 
membrane of A. baumannii [56]. PEG-AuNPs were synthesized using a very similar, multistep 
approach, and used as a control group that lacked colistin decoration.  
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Scheme 1. Synthesis scheme of Col-PEG-AuNP and schematic of interaction between Col-PEG-
AuNPs and A. baumannii. 
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3.2. Characterization of functionalized AuNPs 
TEM images consisted of highly mono-disperse NPs, as shown in Figure 3.1, with an 
average NP core size of 23.2 nm. The EDS capabilities of the TEM confirmed the presence of 
gold in the core by characteristic X-rays at 2.120, 9.712, and 11.442 eV (see Fig. S1 in 
Appendix).  
Figure 3.1. TEM, representative images of nanoparticles. A) AuNP, B) PEG-AuNP, C) Col-
PEG-AuNP 
 
3.3. Confirmation of Colistin-PEG3400-OPSS and NHS-PEG3400-OPSS conjugation to AuNPs 
The successful conjugation of Colistin-PEG3400-OPSS and NHS-PEG3400-OPSS to 
AuNPs was confirmed through zeta potential, size, and H1 NMR spectroscopy measurements. 
The zeta potential of Col-PEG-AuNPs was significantly greater than control PEG-AuNPs or 
untreated AuNPs (Table 3.1). This increase in zeta potential was consistent with decoration of 
the AuNPs with strongly cationic colistin. 
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Table 3.1: NP Zeta Potentials (ζ) 
Sample ζ (mV) 
AuNP -42.8±2.1 
PEG-AuNP -26.1±2.5* 
Col-PEG-AuNP -6.37±1.2* 
 
Table 3.1. Functionalization of AuNPs with NHS-PEG3400-OPSS or Colistin-PEG3400-OPSS 
significantly increased AuNP zeta potential towards more positive values. ANOVA and post hoc 
analysis prove that both Col-PEG-AuNP and PEG-AuNP zeta-potentials are significantly 
different than AuNP zeta-potential. Also, Col-PEG-AuNP and PEG-AuNP zeta-potentials are 
significantly different comparatively.  *p < 0.05 
 
Passivating the AuNPs through PEGylation alone reduced the zeta potential of untreated 
AuNPs, presumably due to the partial shielding of the original surface charge. The addition of 
colistin to the Col-PEG-AuNPs further increased the zeta potential, presumably due to the 
colistin molecule corona, which is cationically charged at physiological pH values.  
Size measurements of the PEG-AuNPs and Col-PEG-AuNPs (Fig. 3.2A) supported 
ligand conjugation to the AuNPs and allowed an estimation of ligand length. The Colistin-
PEG3400-OPSS ligand was approximately 8.5 nm in length when bound to AuNPs, based on a 
diameter that was roughly 17 nm larger than that of unconjugated AuNPs. Conjugation of NHS-
PEG3400-OPSS had a similar effect on size, thereby providing further confidence of the 
successful generation of PEG-AuNPs.  
The hydrodynamic radii of Col-PEG-AuNPs were smaller than those of PEG-AuNPs, as 
reported by DLS (Fig. 3.2B). Attraction of the positively charged colistin molecules to the 
negatively charged AuNP surface was presumed to change the PEG linker conformation, 
resulting in the observed decrease in ligand length, relative to PEG-AuNPs that have a much 
greater negative zeta potential. 
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Figure 3.2. Functionalization of AuNPs with NHS-PEG3400-OPSS or Colistin-PEG3400-OPSS 
significantly increased AuNP size. A) Nanoparticle diameter was estimated by DLS. B) Mean 
size of each nanoparticle. ANOVA and post hoc analysis prove that both Col-PEG-AuNP and 
PEG-AuNP size are significantly different than AuNP size. Also, Col-PEG-AuNP and PEG-
AuNP size are significantly different comparatively.  *p < 0.05 
 
H1 NMR spectroscopy confirmed conjugation of colistin to the AuNPs (Fig. 3.3A). The 
Colistin-PEG3400-OPSS ligands were treated with iodine to decouple the ligands from the AuNP 
surface and then measured using H1 NMR [68]. This decoupling approach was utilized in order 
to prevent peak broadening due to the presence of AuNPs in the sample. 
H1 NMR results are shown in Figure 3.3, with the supernatant from iodine treated Col-
PEG-AuNPs shown in Figure 3.3A and free colistin shown in Figure 3.3B. The protonated amine 
groups of colistin are identifiable in both spectrums (Fig. 3.3A, 8.31ppm; 3.3B, 8.38 ppm), 
consistent with successful conjugation of colistin to the AuNPs. Conjugation of colistin to the 
Sample Size (d.nm) 
AuNP 23.3±1.2 
PEG-AuNP 45.3±2.3* 
Col-PEG-AuNP 39.4±2.5* 
 A) 
B) 
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PEG3400-OPSS linker was expected to cause diamagnetic shielding, increasing the electron 
density surrounding the colistin molecule. The physical shift of the protonated colistin amine 
peak upfield, as seen by comparing Figure 3.3A to Figure 3.3B, is consistent with diamagnetic 
shielding and is further evidence that the colistin was bound to the PEG3400-OPSS linker.  
The supernatant of Col-PEG-AuNPs without the addition of iodine was also analyzed 
using H1 NMR (Fig. 3.3C) to estimate the amount of colistin containing molecules that were not 
particle bound. The relative gain and number of counts taken to generate the H1 NMR spectrum 
of the non-iodinated Col-PEG-AuNP sample were scaled to allow direct comparison to the 
iodinated Col-PEG-AuNP H1 NMR spectrum.  
Due to the absence of a protonated amine peak (8.31 ppm) in the H1 NMR spectrum of 
non-iodinated Col-PEG-AuNP (Fig. 3.3C), it was estimated that 100% of total colistin was 
particle bound. Stoichiometry of the reaction and H1 NMR data support a concentration of 
colistin bound to particles of 15  µμΜ  colsitin mg  AuNP, or 3500 colistin ligands per AuNP. This 
reflects approximately 95% of total AuNP surface coverage, based on a 0.35 nm2 PEG footprint 
area [69]. This was the maximum number of colistin containing ligands that could be loaded onto 
the surface of a single AuNP while remaining water dispersible. The H1 NMR spectrum of iodine 
treated PEG-AuNPs is shown in Figure 3.3D. It can be seen that no signal was present at 8.31 
ppm, indicating the absence of colistin in the sample.   
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Figure 3.3. H1 NMR spectrum of (A) iodinated Col-PEG-AuNP supernatant verified that 
approximately 100% of colistin-containing molecules were bound to AuNPs. A) Supernatant of 
iodinated Col-PEG-AuNPs. The peak indicated at 8.31 ppm was assigned to the protonated 
amine groups of colistin. The presence of protonated amine groups in (A) confirmed successful 
colistin conjugation. B) Free colistin. The peak indicated at 8.38 ppm was assigned to the 
protonated amine groups of colistin. C) Supernatant of pelleted, non-iodinated Col-PEG-AuNPs. 
No peak was present at 8.31 ppm, indicating the absence of colistin in the supernatant. D) 
Supernatant of iodinated PEG-AuNPs. No peak was present at 8.31 ppm, indicating a colistin 
concentration lower than the limit of detection. 
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3.4. In vitro cytotoxicity studies 
AlamarBlue is a cell membrane-permeable dye that both changes fluorescent properties 
and color in response to a chemical reduction caused by cell metabolic activity [70]. With 
alamarBlue it is possible to compare control group cell viability against experimental group cell 
viability, from which cytotoxicity can be analyzed quantitatively. After a 24 h incubation period, 
the cell viability of mammalian cells treated with Col-PEG-AuNPs or PEG-AuNPs was no 
different than untreated cells (Ctrl) (Fig. 3.4A, 3.4B).  
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Figure 3.4. (A) Col-PEG-AuNPs and (B) PEG-AuNPs demonstrated cellular compatibility with 
HUVEC and HepG2 cells. HUVEC and HepG2 cells were treated with different nanoparticle 
formulations at various concentrations. A) HUVEC and HepG2 cell viability was quantified by 
the alamarBlue viability assay following 24 h treatment with Col-PEG-AuNPs. B) HUVEC and 
HepG2 cell viability was quantified by the alamarBlue viability assay following 24 h treatment 
with PEG-AuNPs. Treatment with Col-PEG-AuNPs or PEG-AuNPs did not cause cell toxicity. 
Data were normalized to control cells (Ctrl, 0.0), and are shown as mean ± SD (n = 3). (p-values 
not significant) 
 
Free colistin cytotoxicity was also evaluated in vitro using HepG2 and HUVEC 
mammalian cell lines with alamarBlue [62]. Cell viability above 90% was observed with free 
colistin concentrations less than 90 µM. In comparison, cell viability of only about 80% was 
observed for free colistin at a concentration of 900 µM (Fig. 3.5). The intravenous colistin 
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dosage recommended in the United States for sepsis treatment is 5 mg per kilogram (kg) of body 
weight [71]. Based on the average adult weight of 80 kg in the United States and blood volume 
of 5 liters, this dose, confined to the 5-liter blood volume of an average adult, results in an initial 
colistin concentration of 70 µM. 5 mg/kg of colistin, distributed in the 52 liters of water of the 
average 80 kg human (65% water) [72], results in a colistin concentration of 6.7 µM. The 
maximum low toxicity colistin dosage administered to cell cultures (90 µM) was consistent with 
the upper and lower bounds of colistin concentrations administered in clinically approved 
treatments.   
 
 
 
 
 
 
 
 
 
Figure 3.5. Cellular toxicity was not induced by free colistin at concentrations less than 90 µM. 
HUVEC and HepG2 cell viability was quantified by the alamarBlue viability assay following 24 
h treatment with colistin. Treatment with colistin caused cellular toxicity at a colistin 
concentration of 900 µM in both cell types. Data were normalized to control cells (Ctrl, 0), and 
are shown as mean ± SD (n = 3). *p < 0.05 compared to Ctrl. 
 
3.5. In vitro hemocompatibility 
Avoiding destabilization and nonspecific interactions with cells and other blood 
components is key to general hemocompatibility and important for future applications of these 
materials in contact with blood. A design goal was to maximize the allowable duration for blood 
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contact time with NPs in order to allow for passive bacterial association or active bacterial 
targeting by intact, bioactive NPs. Ex vivo experiments in human whole blood were done to 
measure nonspecific RBC interactions and the stability of AuNPs. After 1 h incubation in a 
solution of isolated RBCs, Col-PEG-AuNPs, PEG-AuNPs, and free colistin were retained in the 
serum fraction and did not cause hemolysis (Appendix Table S1 and Table S2). PEGylation 
improves hemocompatibility of similarly sized NPs [73], and we hypothesized that surface 
PEGylation could be an avenue to further enhance stability. The PEGylation design presumably 
contributed to the observed lack of adverse interactions between blood cells and Col-PEG-
AuNPs. Greater opportunity for Col-PEG-AuNP interaction with A. baumannii is one 
consequence of the extended allowable blood contact time exhibited by these NPs.  
3.6. Nanoparticle binding to A. baumannii  
 The primary component of the outer membrane of Gram-negative bacteria, including A. 
baumannii, is LPS. LPS is composed of lipid A, a core oligosaccharide, and an outer 
polysaccharide. Lipid A is the innermost aspect of the LPS, as well as the most conserved 
component of the structure [74]. The proposed binding mechanism between colistin and A. 
baumannii involves lipid A. At physiological pH values, the primary amine groups of the colistin 
heptapeptide ring and fatty acid tail become protonated, thereby allowing electrostatic 
interactions with the negatively charged phosphate groups of lipid A [56]. Initial electrostatic 
interaction between colistin and A. baumannii leads to hydrophobic interaction between the fatty 
acid tail of colistin and the acyl chains of lipid A [57]. The conjugation chemistry of Colistin-
PEG3400-OPSS was designed to preserve and protect the molecular characteristics of colistin that 
are responsible for antibiotic activity and binding to A. baumannii. Conjugation of colistin to the 
heterobifunctional PEG was hypothesized to use a single amine group of the colistin 
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heptapeptide ring. This colistin conformation leaves the fatty acid tail of colistin uninhibited and 
free to interact with the lipid A on the surface of A. baumannii.  
Col-PEG-AuNPs associated with the cell wall of A. baumannii, as imaged by STEM (Fig. 
3.6A). High-angle annular dark-field (HAADF)-EDS analysis of Col-PEG-AuNPs association 
with A. baumannii, Figure 3.6B, verified that gold (Au) and nitrogen (N) were present in the 
EDS spectrum (see Fig. S2 of Appendix), thereby confirming the presence of Col-PEG-AuNPs 
and bacteria [75], [76]. In the HAADF-EDS image shown in Figure 3.6B, contrast is directly 
related to atomic number. This allowed for identification of chemical elements present in the 
sample. In this case, gold was pseudocolored to identify the Col-PEG-AuNPs (Fig. 3.6C), 
whereas nitrogen was pseudocolored to identify the bacteria (Fig. 3.6D). Further analysis of 
Figure 3.6B provided the complete elemental make-up of the A. baumannii (Figure S3 of the 
Appendix). Figures 3.6A and 3.6B suggest that Col-PEG-AuNPs attached to the surface of A. 
baumannii.  PEG-AuNPs did not bind to the bacterial surface (Fig. 3.6E), confirming that 
colistin is an effective targeting ligand. The HAADF-EDS image shown in Figure 3.6F allowed 
for identification of chemical elements present in the sample. The EDS spectrum (see Fig. S4 of 
Appendix) verified the presence of bacteria through elemental analysis, but elemental gold was 
not present in the spectrum (Fig. 3.6G, Fig. 3.6H), indicating that PEG-AuNPs did not bind to A. 
baumannii.  
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Figure 3.6. STEM imaging of (A) Col-PEG-AuNP association with A. baumannii suggests that 
the targeting ligand of colistin is required for nanoparticle binding to A. baumannii. A) STEM of 
Col-PEG-AuNPs bound to A. baumannii. B) HAADF-EDS view of the sample analyzed in panel 
(A). The sample was analyzed via HAADF imaging in combination with EDS for the presence of 
gold (C) and nitrogen (D). The EDS spectrum behind each pixel was used for elemental image 
analysis. E) STEM of PEG-AuNPs incubated with A. baumannii. F) HAADF-EDS view of the 
sample analyzed in panel (E). The sample was analyzed via EDS for the presence of gold (G) 
and nitrogen (H).  
 
 
Col-PEG-AuNPs PEG-AuNPs 
Col-PEG-AuNPs PEG-AuNPs 
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3.7. A. baumannii binding kinetics 
Col-PEG-AuNP binding to A. baumannii was characterized as a function of the extent of 
colistin decoration per NP (Col:NP ratio), holding the NP:A. baumannii ratio constant. Fastest 
binding occurred when using a 15 µM colistin concentration functionalized to the AuNP surface, 
which is consistent with colistin concentrations administered in clinically approved treatments 
[71]. To achieve a 15 µM colistin concentration, approximately 3500 Colistin-PEG3400-OPSS 
ligands were bound to a single AuNP, based on the molecular dimensions of PEG, number of 
AuNPs, and volume of the AuNPs. The kinetics of Col-PEG-AuNP association with A. 
baumannii was characterized by a spin filtration technique as described in section 2.2.10. 
Following the addition of A. baumannii to Col-PEG-AuNPs, the rate of association was 
evaluated over a 2 h time period.  
Nanoparticle attachment to A. baumannii was dependent upon the presence of the colistin 
targeting ligand, as shown in Figure 3.7. The rate of Col-PEG-AuNP binding to A. baumannii is 
described by a two-parameter, exponential curve in the form of: 
  Α = Α!"# ∗ 1− 𝑒!! !                                                                                                                                             (1) 
where Α (number) represents the number of Col-PEG-AuNPs bound to a single A. baumannii, 
and t (min) represents time. The constants for the exponential curve are Α!"# (maximum number 
of Col-PEG-AuNPs per A. baumannii), the final asymptotic value of this system, and 𝜏 (min), 
the time constant. The maximum number of Col-PEG-AuNPs bound to a single A. baumannii 
(Α!"#) was estimated to be 1316±182. The time constant, 𝜏, represents the time required for 
63% of maximal Col-PEG-AuNP binding per A. baumannii, or Α!"#. In this system, 𝜏 is 
equivalent to 10.7±2.1 minutes. Therefore, Eq. (1) can be more completely represented as: Α = 1316 ∗ 1− 𝑒!! !".!                                                                                                                                             (2) 
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Half-maximal binding occurs when Α is equal to half of Α!"#, or when 658 Col-PEG-AuNPs are 
bound to a single A. baumannii. Half-maximal binding occurred at 7.5 minutes. The PEG-AuNP 
control samples, in the absence of colistin, did not exhibit time dependent binding behavior (Fig. 
3.7), further confirming colistin as necessary for PEG-AuNP association with A. baumannii.  
 
 
Figure 3.7. Col-PEG-AuNPs rapidly and specifically associated with A. baumannii, reaching 
50% maximum saturation within 7.5 min, whereas PEG-AuNPs did not specifically bind the 
bacteria. Interaction of Col-PEG-AuNPs with A. baumannii was significantly different than the 
interaction of PEG-AuNPs with A. baumannii, as indicated at the 5 min time point. ANOVA and 
post hoc analysis prove that Col-PEG-AuNPs per A. baumannii at all time points are 
significantly different than those of PEG-AuNPs per A. baumannii.   
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CHAPTER 4 
 
Summary 
 
This work, for the first time, presented a mathematical description of the binding kinetics 
between colistin functionalized nanoparticles and A. baumannii. The novel nanoparticle system 
with colistin as an A. baumannii targeter covalently conjugated to the distal end of PEG 
eliminated the possibility of colistin disassembly through electrostatic interactions. Additionally, 
the use of a ligand reduced colistin steric hindrance and increased nanoparticle-bacteria 
association. On average, 658 colistin-functionalized nanoparticles associated with a single A. 
baumannii cell in approximately 7 min. This rapid rate of nanoparticle-bacteria association 
enables the consideration of new approaches to bacterial detection and isolation. Functionalizing 
magnetic core nanoparticles with Colisitn-PEG3400-OPSS is projected to support magnetic 
extraction of particle-bound A. baumannii using methods similar to Singh et al. and Lee et al. 
[51], [58]. Because colistin is FDA approved and readily available, this design may be further 
developed and used in water treatment facilities to rid contaminated water of deadly pathogens, 
such as A. baumannii.  
Nanoparticle bound Colisitn-PEG3400-OPSS is biocompatible and can, therefore, be 
injected directly into the source of contaminated water for in situ treatment. Colisitn-PEG3400-
OPSS readily binds to its bacterial target, as indicated by Figure 3.7. Nanoparticles 
functionalized with Colisitn-PEG3400-OPSS are an effective approach to water treatment because 
only small amounts are needed due to the significant ligand reactivity, as well as the large 
surface area of the nanoparticles. Their superiority to nanofiltration membranes, nanoporous 
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ceramics, nanofibers, and nanocatalysts lies in the fact that they offer a high surface area to 
volume ratio by being small and without introducing mass transfer limitations common to porous 
structures. Nanoparticles functionalized with Colisitn-PEG3400-OPSS are versatile and can be 
applied to both treat effluents and sediment matrices. Also, the Colisitn-PEG3400-OPSS ligand 
could potentially be bound to membranes for ex situ applications. 
In the future, the use of colistin-functionalized nanoparticles for the rapid binding of A. 
baumannii may also enable new advances in the detection and purification of Gram-negative 
bacteria from other environmental samples, such as food and soil. A. baumannii proliferates over 
time, therefore, the detection of the bacterium in its early stages would be useful in preventing 
the transmission of infections. Also, the technology developed in this work could potentially be 
useful in the hospital setting where A. baumannii is known to cause a range of different 
infections, including the blood-borne infection sepsis. The Colistin-PEG3400-OPSS ligand 
developed in this work for the capture of A. baumannii has to potential to be used for the rapid 
selection of bacteria from blood.  The binding kinetics seen between the Col-PEG-AuNPs and A. 
baumannii could allow for rapid NP-bacteria association in blood, thereby facilitating clinical 
applications with extracorporeal devices. Also, because colistin has been approved for use in the 
clinical setting for decades, the Colistin-PEG3400-OPSS ligand presents major advantages over 
other genetically engineered and biomacromolecular ligands used in this context.   
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Appendix: 
Figure S1. TEM-EDS of Col-PEG-AuNPs verified the presence of Au in the sample, confirming 
the nanoparticle core composition. The copper (Cu) signals were a result of the carbon film-
backed copper grids used.  
 
 
 
 
 
 
 
 
 
 
 41 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table S1. Red Blood Cell Hemolysis 
Sample 
Hemolysis 
(%) 
0.25 mM Col-PEG-AuNPs -0.3 ± 0.4 
0.25 mM PEG-AuNPs -2.7 ± 0.8 
0.5 mM Col-PEG-AuNPs 1.2 ± 0.5 
0.5 mM PEG-AuNPs -0.4 ± 0.8 
1.0 mM Col-PEG-AuNPs -3.0 ± 0.2 
1.0 mM PEG-AuNPs -0.2 ± 0.7 
2.0 mM Col-PEG-AuNPs 0.2 ± 0.4 
2.0 mM PEG-AuNPs -0.6 ± 0.8 
Positive control (20% triton-X) 100 ± 1.9 
Negative control (PBS, pH 7.4) 0.0 ± 0.0 
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Table S2. Red Blood Cell Hemolysis 
Sample 
Hemolysis 
(%) 
0.2 mM Free Colistin -0.7 ± 0.6 
0.4 mM Free Colistin -0.8 ±1.1 
0.9 mM Free Colistin 0.8 ± 1.5 
900 mM Free Colistin -0.4 ± 0.8 
Positive control (20% triton-X) 100 ±1.9 
Negative control (PBS, pH 7.4) 0.0 ± 0.0 
 43 
 
Figure S2. EDS spectrum of Fig. 3.6B confirmed that Col-PEG-AuNPs, indicated by Au peaks, 
were associated with A. baumannii, indicated by phosphate (P), potassium (K), sodium (Na), 
nitrogen (N), and chlorine (Cl) peaks. The Cu signals were a result of the carbon film-backed 
copper grids used.  
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Figure S3. HAADF-STEM images in combination with EDS further confirmed the elemental 
composition of A. baumannii. N, K, Cl, P, and Na are the core elements that make up A. 
baumannii.    
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Figure S4. EDS spectrum of PEG-AuNPs incubated with A. baumannii lacks Au, indicating that 
PEG-AuNPs were not bound to A. baumannii. P, K, Na, and Cl peaks confirmed the presence of 
bacteria. The Cu signals were a result of the carbon film-backed copper grids used.  
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Figure S5. AuNP standard concentration curve based on absorbance. 
 47 
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